Lyophilized Peptide Melanotan 1 / Mt-1 10mg Human Supplements

Model NO.: 75921-69-6
Trademark: Desen Nutrition
Transport Package: Box-Packed
Specification: 2mg
Origin: China
HS Code: 2500666303
Model NO.: 75921-69-6
Trademark: Desen Nutrition
Transport Package: Box-Packed
Specification: 2mg
Origin: China
HS Code: 2500666303

Lyophilized Peptide Melanotan 1 / MT-1 10mg Human Supplements

 

Quick View:

 

Product Name Melanotan-I
Synonyms MT1 Peptides; Melanotan; Melanotan-1; Melanotan I; CUV1647
MF C78H111N21O19
MW 1646.845
CAS number 75921-69-6
Appearance Freeze-Dried White Powder
Standard Pharmaceutical
Purity Not Lower Than 98.00%
Application Type Injection
Supplying Form Lyophilized Powder In Vials / Pure Raw Powder No Vial
Custom Supported.
. Various Colors of Flip off Caps
. 1mg/vial, 2mg/vial , 5mg/vial, 10mg/vial , or no vials .
. Peptides Blend According to Your Demand. such as CJC GHRP2 Combo, CJC Ipamorelin Combo......

 

Stability: Lyophilized Melanotan-I although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution MT-I should be stored at 4°C between 2-7 days and for future use below -18°C.

For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).

Please prevent freeze-thaw cycles.

Purity: Greater than 98.0% as determined by RP-HPLC.

Usage: Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household

 

Descriptions:

 

Both Melanotan-1 and Melanotan 2 are analogs of the peptide hormone alpha-melanocyte stimulating hormone (α-MSH) that tend to induce skin tanning. Unlike Melanotan 1, Melanotan 2 has been shown to have aphrodisiac properties, the additional effect of increasing libido. Melanotan-1 is a non selective agonist of the melanocortin receptors (MC1R,MC3-5R). As an analogue of α-MSH, its mechanism of action is biomimicry of the natural mammalian tanning process.

 

The Development of Melanotan 1:


The initial creation of the Melanotan 1 peptide tanning analogue can be credited to the University of Arizona. During the course of study aimed at developing a defense against skin cancer, focus was placed on developing a method of stimulating natural melanogenesis, or the natural production of melanin in the skin, without direct exposure to the potentially harmful ultraviolet radiation in sunlight. Initially, University of Arizona researchers attempted to directly administer the naturally occurring hormone alpha-MSH in order to elicit this desired result. Although this strategy exhibited promising results, it was determined that the naturally occurring MSH had a prohibitively short half-life to be of realistic use as a therapeutic remedy. However, the positive results gleaned from MSH administration encouraged further research into the development of Melanotan 1, which exhibits similar effects whilst possessing an extended half-life for functional therapeutic utilization. The researchers, headed by Victor J. Hruby and Mac E. Hadley, found a peptide, [Nle4, D-Phe7]-α-MSH, that was approximately 1,000 times more potent than natural α-MSH. They named this new peptide molecule "Melanotan" (later Melanotan-1).

 

Melanotan-1 Mechanism of Action - How Melanotan-1 Works!


Melanotan produces its photoprotective effects by triggering a 'signaling cascade' via its activation of the MC1R on melanin-producing cells known as melanocytes. Upon Melanotan binding with the MC1R on the surface of melanocytes in the epidermal layer of the skin, it begins a series of actions and reactions that result in melanocytes favoring the production of eumelanin (photoprotective black/brown pigment). The initial binding activates the MC1R leading to the activation of adenylate cyclase (AC) and stimulation of the production of cyclic adenosine monophosphate (cAMP). cAMP in turn activates protein kinase A (PKA) resulting in the phosphorylation of the cAMP response element-binding (CREB). Phosphorylated CREB will bind to the cAMP response element (CRE) on the microphthalmia-associated transcription factor (MITF) gene leading to the synthesis of the MITF protein. MITF has the ability to activate several genes by binding to them, including the MC1R gene and the genes involved in melanogenesis. This results in increased concentrations of the melanogenic enzymes within the melanocyte.

 

 

Lyophilized Peptide Melanotan 1 / MT-1 10mg Human Supplements

 

Quick View:

 

Product Name Melanotan-I
Synonyms MT1 Peptides; Melanotan; Melanotan-1; Melanotan I; CUV1647
MF C78H111N21O19
MW 1646.845
CAS number 75921-69-6
Appearance Freeze-Dried White Powder
Standard Pharmaceutical
Purity Not Lower Than 98.00%
Application Type Injection
Supplying Form Lyophilized Powder In Vials / Pure Raw Powder No Vial
Custom Supported.
. Various Colors of Flip off Caps
. 1mg/vial, 2mg/vial , 5mg/vial, 10mg/vial , or no vials .
. Peptides Blend According to Your Demand. such as CJC GHRP2 Combo, CJC Ipamorelin Combo......

 

Stability: Lyophilized Melanotan-I although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution MT-I should be stored at 4°C between 2-7 days and for future use below -18°C.

For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).

Please prevent freeze-thaw cycles.

Purity: Greater than 98.0% as determined by RP-HPLC.

Usage: Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household

 

Descriptions:

 

Both Melanotan-1 and Melanotan 2 are analogs of the peptide hormone alpha-melanocyte stimulating hormone (α-MSH) that tend to induce skin tanning. Unlike Melanotan 1, Melanotan 2 has been shown to have aphrodisiac properties, the additional effect of increasing libido. Melanotan-1 is a non selective agonist of the melanocortin receptors (MC1R,MC3-5R). As an analogue of α-MSH, its mechanism of action is biomimicry of the natural mammalian tanning process.

 

The Development of Melanotan 1:


The initial creation of the Melanotan 1 peptide tanning analogue can be credited to the University of Arizona. During the course of study aimed at developing a defense against skin cancer, focus was placed on developing a method of stimulating natural melanogenesis, or the natural production of melanin in the skin, without direct exposure to the potentially harmful ultraviolet radiation in sunlight. Initially, University of Arizona researchers attempted to directly administer the naturally occurring hormone alpha-MSH in order to elicit this desired result. Although this strategy exhibited promising results, it was determined that the naturally occurring MSH had a prohibitively short half-life to be of realistic use as a therapeutic remedy. However, the positive results gleaned from MSH administration encouraged further research into the development of Melanotan 1, which exhibits similar effects whilst possessing an extended half-life for functional therapeutic utilization. The researchers, headed by Victor J. Hruby and Mac E. Hadley, found a peptide, [Nle4, D-Phe7]-α-MSH, that was approximately 1,000 times more potent than natural α-MSH. They named this new peptide molecule "Melanotan" (later Melanotan-1).

 

Melanotan-1 Mechanism of Action - How Melanotan-1 Works!


Melanotan produces its photoprotective effects by triggering a 'signaling cascade' via its activation of the MC1R on melanin-producing cells known as melanocytes. Upon Melanotan binding with the MC1R on the surface of melanocytes in the epidermal layer of the skin, it begins a series of actions and reactions that result in melanocytes favoring the production of eumelanin (photoprotective black/brown pigment). The initial binding activates the MC1R leading to the activation of adenylate cyclase (AC) and stimulation of the production of cyclic adenosine monophosphate (cAMP). cAMP in turn activates protein kinase A (PKA) resulting in the phosphorylation of the cAMP response element-binding (CREB). Phosphorylated CREB will bind to the cAMP response element (CRE) on the microphthalmia-associated transcription factor (MITF) gene leading to the synthesis of the MITF protein. MITF has the ability to activate several genes by binding to them, including the MC1R gene and the genes involved in melanogenesis. This results in increased concentrations of the melanogenic enzymes within the melanocyte.

 

 

PVB Film-Automotive

Pvb Film-Automotive,Pvb Interlayer Glass,Pvb Film Glass,Sgp Glass Interlayer

HUAKAI FENGSHI TECHNOLOGY (CHONGQING) CO., LTD. , https://www.cqhkpvb.com